RankingsPricing
  1. US-listed companies
  2. Citius Pharmaceuticals, Inc.
  3. Financials
  4. Total cash & short-term investments

Citius Pharmaceuticals, Inc.CTXR

Market cap
$11.32M
P/E ratio
SummaryFinancials
Period EndTotal cash & short-term investments (Million USD)YoY (%)
Sep 30, 20243-87.72%
Sep 30, 202326-36.51%
Sep 30, 202242-40.47%
Sep 30, 202170+405.59%
Sep 30, 202014+75.58%
Sep 30, 20198-14.05%
Sep 30, 20189+3020.09%
Sep 30, 20160-56.47%
Sep 30, 20151+Infinity%
Sep 30, 20130-100.00%
Sep 30, 20120-36.32%
Sep 30, 20110

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)